Cite
HARVARD Citation
Hentzien, M. et al. (2022). A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab. Lancet infectious diseases. 22 (9), pp. 1278-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hentzien, M. et al. (2022). A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab. Lancet infectious diseases. 22 (9), pp. 1278-. [Online].